Sunmax Biotechnology Co Ltd (4728) — Capital Reinvestment Ratio
Sunmax Biotechnology Co Ltd (4728) has a Capital Reinvestment Ratio of 0.11x as of September 2025, meaning it reinvests 0% of its operating cash flow (NT$160.84 Million) in capital expenditures (NT$17.44 Million). See Sunmax Biotechnology Co Ltd (4728) balance sheet quality index to measure how much of total assets are equity-financed.
Capital Reinvestment Ratio
Operating Cash Flow
Capital Expenditures
Data as of
Sunmax Biotechnology Co Ltd Capital Reinvestment Ratio (2016–2024)
This chart tracks Sunmax Biotechnology Co Ltd's Capital Reinvestment Ratio across 9 annual periods. Check Sunmax Biotechnology Co Ltd cash flow reinvestment rate to assess the company's total reinvestment commitment from operating cash flow.
Annual Capital Reinvestment Ratio for Sunmax Biotechnology Co Ltd (2016–2024)
Year-by-year Capital Reinvestment Ratio for Sunmax Biotechnology Co Ltd from 2016 to 2024. For live market cap and broader valuation context, see Sunmax Biotechnology Co Ltd market capitalisation.
| Year | Reinvestment Ratio | Operating CF (TWD) | Capital Expenditures | YoY Change |
|---|---|---|---|---|
| 2024 | 0.09x | NT$397.37 Million | NT$36.61 Million | ▼ -29.2% |
| 2023 | 0.13x | NT$848.56 Million | NT$110.39 Million | ▼ -70.7% |
| 2022 | 0.44x | NT$342.97 Million | NT$152.03 Million | ▼ -57.8% |
| 2021 | 1.05x | NT$243.28 Million | NT$255.43 Million | ▲ +212.3% |
| 2020 | 0.34x | NT$386.97 Million | NT$130.10 Million | ▲ +611.3% |
| 2019 | 0.05x | NT$289.51 Million | NT$13.68 Million | ▲ +1.0% |
| 2018 | 0.05x | NT$100.83 Million | NT$4.72 Million | ▼ -45.0% |
| 2017 | 0.09x | NT$37.09 Million | NT$3.15 Million | ▼ -70.2% |
| 2016 | 0.29x | NT$16.58 Million | NT$4.73 Million | — |